|
1.
|
Coussens LM and Werb Z: Inflammation and
cancer. Nature. 420:860–867. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Grivennikov SI, Greten FR and Karin M:
Immunity, inflammation, and cancer. Cell. 140:883–899. 2010.
View Article : Google Scholar
|
|
3.
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008.
View Article : Google Scholar
|
|
4.
|
Balkwill F and Mantovani A: Inflammation
and cancer: back to Virchow? Lancet. 357:539–545. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Engels EA, Wu X, Gu J, Dong Q, Liu J and
Spitz MR: Systematic evaluation of genetic variants in the
inflammation pathway and risk of lung cancer. Cancer Res.
67:6520–6527. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Tindall EA, Severi G, Hoang HN, et al:
Comprehensive analysis of the cytokine-rich chromosome 5q31.1
region suggests a role for IL-4 gene variants in prostate cancer
risk. Carcinogenesis. 31:1748–1754. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Kishimoto T: Interleukin-6: from basic
science to medicine – 40 years in immunology. Annu Rev Immunol.
23:1–21. 2005.
|
|
8.
|
Katsumata N, Eguchi K, Fukuda M, et al:
Serum levels of cytokines in patients with untreated primary lung
cancer. Clin Cancer Res. 2:553–559. 1996.PubMed/NCBI
|
|
9.
|
Bromberg JF, Wrzeszczynska MH, Devgan G,
et al: Stat3 as an oncogene. Cell. 98:295–303. 1999. View Article : Google Scholar
|
|
10.
|
Grivennikov S, Karin E, Terzic J, et al:
IL-6 and Stat3 are required for survival of intestinal epithelial
cells and development of colitis-associated cancer. Cancer Cell.
15:103–113. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Walter M, Liang S, Ghosh S, Hornsby PJ and
Li R: Interleukin 6 secreted from adipose stromal cells promotes
migration and invasion of breast cancer cells. Oncogene.
28:2745–2755. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Sullivan NJ, Sasser AK, Axel AE, et al:
Interleukin-6 induces an epithelial-mesenchymal transition
phenotype in human breast cancer cells. Oncogene. 28:2940–2947.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Fishman D, Faulds G, Jeffery R, et al: The
effect of novel polymorphisms in the interleukin-6 (IL-6) gene on
IL-6 transcription and plasma IL-6 levels, and an association with
systemic-onset juvenile chronic arthritis. J Clin Invest.
102:1369–1376. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Belluco C, Olivieri F, Bonafe M, et al:
-174 G>C polymorphism of interleukin 6 gene promoter affects
interleukin 6 serum level in patients with colorectal cancer. Clin
Cancer Res. 9:2173–2176. 2003.
|
|
15.
|
Xu B, Niu XB, Wang ZD, et al: IL-6
-174G>C polymorphism and cancer risk: a meta-analysis involving
29,377 cases and 37,739 controls. Mol Biol Rep. 38:2589–2596.
2011.
|
|
16.
|
Yu KD, Di GH, Fan L, Chen AX, Yang C and
Shao ZM: Lack of an association between a functional polymorphism
in the interleukin-6 gene promoter and breast cancer risk: a
meta-analysis involving 25,703 subjects. Breast Cancer Res Treat.
122:483–488. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Moher D, Liberati A, Tetzlaff J and Altman
DG: Preferred reporting items for systematic reviews and
meta-analyses: the PRISMA statement. BMJ. 339:b25352009. View Article : Google Scholar
|
|
18.
|
Stroup DF, Berlin JA, Morton SC, et al:
Meta-analysis of observational studies in epidemiology: a proposal
for reporting. Meta-analysis of Observational Studies in
Epidemiology (MOOSE) group. JAMA. 283:2008–2012. 2000. View Article : Google Scholar
|
|
19.
|
Yu W, Gwinn M, Clyne M, Yesupriya A and
Khoury MJ: A navigator for human genome epidemiology. Nat Genet.
40:124–125. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Cochran WG: The combination of estimates
from different experiments. Biometrics. 10:101–129. 1954.
View Article : Google Scholar
|
|
21.
|
Dickersin K and Berlin JA: Meta-analysis:
state-of-the-science. Epidemiol Rev. 14:154–176. 1992.
|
|
22.
|
Higgins JP, Thompson SG, Deeks JJ and
Altman DG: Measuring inconsistency in meta-analyses. BMJ.
327:557–560. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Lau J, Ioannidis JP and Schmid CH: Summing
up evidence: one answer is not always enough. Lancet. 351:123–127.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Patsopoulos NA, Evangelou E and Ioannidis
JP: Sensitivity of between-study heterogeneity in meta-analysis:
proposed metrics and empirical evaluation. Int J Epidemiol.
37:1148–1157. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Mantel N and Haenszel W: Statistical
aspects of the analysis of data from retrospective studies of
disease. J Natl Cancer Inst. 22:719–748. 1959.PubMed/NCBI
|
|
26.
|
DerSimonian R and Laird N: Meta-analysis
in clinical trials. Control Clin Trials. 7:177–188. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Egger M, Davey Smith G, Schneider M and
Minder C: Bias in meta-analysis detected by a simple, graphical
test. BMJ. 315:629–634. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Harbord RM, Egger M and Sterne JA: A
modified test for small-study effects in meta-analyses of
controlled trials with binary endpoints. Stat Med. 25:3443–3457.
2006. View
Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Dossus L, Kaaks R, Canzian F, et al: PTGS2
and IL6 genetic variation and risk of breast and prostate cancer:
results from the Breast and Prostate Cancer Cohort Consortium
(BPC3). Carcinogenesis. 31:455–461. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Foster CB, Lehrnbecher T, Samuels S, et
al: An IL6 promoter polymorphism is associated with a lifetime risk
of development of Kaposi sarcoma in men infected with human
immunodeficiency virus. Blood. 96:2562–2567. 2000.PubMed/NCBI
|
|
31.
|
Morgan L, Cooper J, Montgomery H, Kitchen
N and Humphries SE: The interleukin-6 gene -174G>C and
-572G>C promoter polymorphisms are related to cerebral
aneurysms. J Neurol Neurosurg Psychiatry. 77:915–917. 2006.
|
|
32.
|
Theodoropoulos G, Papaconstantinou I,
Felekouras E, et al: Relation between common polymorphisms in genes
related to inflammatory response and colorectal cancer. World J
Gastroenterol. 12:5037–5043. 2006.PubMed/NCBI
|
|
33.
|
Vairaktaris E, Yapijakis C, Serefoglou Z,
et al: Gene expression polymorphisms of interleukins-1 beta, -4,
-6, -8, -10, and tumor necrosis factors-alpha, -beta: regression
analysis of their effect upon oral squamous cell carcinoma. J
Cancer Res Clin Oncol. 134:821–832. 2008. View Article : Google Scholar
|
|
34.
|
Slattery ML, Wolff RK, Herrick JS, Caan BJ
and Potter JD: IL6 genotypes and colon and rectal cancer. Cancer
Causes Control. 18:1095–1105. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Hirschhorn JN, Lohmueller K, Byrne E and
Hirschhorn K: A comprehensive review of genetic association
studies. Genet Med. 4:45–61. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Iliopoulos D, Hirsch HA and Struhl K: An
epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and
IL6 links inflammation to cell transformation. Cell. 139:693–706.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Iliopoulos D, Jaeger SA, Hirsch HA, Bulyk
ML and Struhl K: STAT3 activation of miR-21 and miR-181b-1 via PTEN
and CYLD are part of the epigenetic switch linking inflammation to
cancer. Mol Cell. 39:493–506. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Okamoto M, Lee C and Oyasu R:
Interleukin-6 as a paracrine and autocrine growth factor in human
prostatic carcinoma cells in vitro. Cancer Res. 57:141–146.
1997.PubMed/NCBI
|
|
39.
|
Yeh HH, Lai WW, Chen HH, Liu HS and Su WC:
Autocrine IL-6-induced Stat3 activation contributes to the
pathogenesis of lung adenocarcinoma and malignant pleural effusion.
Oncogene. 25:4300–4309. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Bromberg J and Wang TC: Inflammation and
cancer: IL-6 and STAT3 complete the link. Cancer Cell. 15:79–80.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
41.
|
Park EJ, Lee JH, Yu GY, et al: Dietary and
genetic obesity promote liver inflammation and tumorigenesis by
enhancing IL-6 and TNF expression. Cell. 140:197–208. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
42.
|
Thompson SG: Why sources of heterogeneity
in meta-analysis should be investigated. BMJ. 309:1351–1355.
1994.PubMed/NCBI
|
|
43.
|
Sterne JA and Egger M: Funnel plots for
detecting bias in meta-analysis: guidelines on choice of axis. J
Clin Epidemiol. 54:1046–1055. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
44.
|
Robinson GE: Genomics. Beyond nature and
nurture Science. 304:397–399. 2004.
|
|
45.
|
Frazer KA, Murray SS, Schork NJ and Topol
EJ: Human genetic variation and its contribution to complex traits.
Nat Rev Genet. 10:241–251. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
46.
|
Cole SW, Arevalo JM, Takahashi R, et al:
Computational identification of gene-social environment interaction
at the human IL6 locus. Proc Natl Acad Sci USA. 107:5681–5686.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
47.
|
Gu W, Du DY, Huang J, et al:
Identification of interleukin-6 promoter polymorphisms in the
Chinese Han population and their functional significance. Crit Care
Med. 36:1437–1443. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
48.
|
Smith AJ, D'Aiuto F, Palmen J, et al:
Association of serum interleukin-6 concentration with a functional
IL6 -6331T>C polymorphism. Clin Chem. 54:841–850.
2008.PubMed/NCBI
|
|
49.
|
Terry CF, Loukaci V and Green FR:
Cooperative influence of genetic polymorphisms on interleukin 6
transcriptional regulation. J Biol Chem. 275:18138–18144. 2000.
View Article : Google Scholar : PubMed/NCBI
|
